Skip to main content

Advertisement

Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Emerging therapies for small cell lung cancer

Fig. 2

Targets and biomarkers for targeted therapy. DLL3, delta-like protein 3; PARP, poly (ADP-ribose) polymerase; PDL-1, programmed death ligand 1; PD1, programmed death 1; CTLA-4, cytotoxic T lymphocyte antigen-4; SLFN11, schlafen family member 11; TMB, tumor mutation burden; IHC, immunohistochemistry; NGS, next-generation sequencing

Back to article page